Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1

Application of dental nanomaterials: potential toxicity to the central nervous system

Authors Feng X, Chen A, Zhang Y, Wang J, Shao L, Wei L

Received 26 December 2014

Accepted for publication 16 March 2015

Published 14 May 2015 Volume 2015:10(1) Pages 3547—3565

DOI https://doi.org/10.2147/IJN.S79892

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 5

Editor who approved publication: Dr Lei Yang

Xiaoli Feng,1 Aijie Chen,1 Yanli Zhang,1 Jianfeng Wang,2 Longquan Shao,1 Limin Wei2

1Nanfang Hospital, Southern Medical University, Guangzhou, 2School and Hospital of Stomatology, Wenzhou Medical University, Wenzhou, People’s Republic of China

Abstract: Nanomaterials are defined as materials with one or more external dimensions with a size of 1–100 nm. Such materials possess typical nanostructure-dependent properties (eg, chemical, biological, optical, mechanical, and magnetic), which may differ greatly from the properties of their bulk counterparts. In recent years, nanomaterials have been widely used in the production of dental materials, particularly in light polymerization composite resins and bonding systems, coating materials for dental implants, bioceramics, endodontic sealers, and mouthwashes. However, the dental applications of nanomaterials yield not only a significant improvement in clinical treatments but also growing concerns regarding their biosecurity. The brain is well protected by the blood–brain barrier (BBB), which separates the blood from the cerebral parenchyma. However, in recent years, many studies have found that nanoparticles (NPs), including nanocarriers, can transport through the BBB and locate in the central nervous system (CNS). Because the CNS may be a potential target organ of the nanomaterials, it is essential to determine the neurotoxic effects of NPs. In this review, possible dental nanomaterials and their pathways into the CNS are discussed, as well as related neurotoxicity effects underlying the in vitro and in vivo studies. Finally, we analyze the limitations of the current testing methods on the toxicological effects of nanomaterials. This review contributes to a better understanding of the nano-related risks to the CNS as well as the further development of safety assessment systems.

Keywords: dental, nanomaterials, central nervous system, toxicity, testing methods, risk assessment

A Letter to the Editor has been received and published for this article.
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Involvement of PINK1/parkin-mediated mitophagy in ZnO nanoparticle-induced toxicity in BV-2 cells

Wei L, Wang J, Chen A, Liu J, Feng X, Shao L

International Journal of Nanomedicine 2017, 12:1891-1903

Published Date: 8 March 2017

Central nervous system toxicity of metallic nanoparticles

Feng XL, Chen AJ, Zhang YL, Wang JF, Shao LQ, Wei LM

International Journal of Nanomedicine 2015, 10:4321-4340

Published Date: 3 July 2015

Readers of this article also read:

Enhanced antitumor effects by docetaxel/LL37-loaded thermosensitive hydrogel nanoparticles in peritoneal carcinomatosis of colorectal cancer

Fan R, Tong A, Li X, Gao X, Mei L, Zhou L, Zhang X, You C, Guo G

International Journal of Nanomedicine 2015, 10:7291-7305

Published Date: 3 December 2015

Biodegradable mesoporous calcium–magnesium silicate-polybutylene succinate scaffolds for osseous tissue engineering

Zhang X, Zhang C, Xu W, Zhong B, Lin F, Zhang J, Wang Q, Ji J, Wei J, Zhang Y

International Journal of Nanomedicine 2015, 10:6699-6708

Published Date: 28 October 2015

Enhancement of encapsulation efficiency of nanoemulsion-containing aripiprazole for the treatment of schizophrenia using mixture experimental design

Fard Masoumi HR, Basri M, Sarah Samiun W, Izadiyan Z, Lim CJ

International Journal of Nanomedicine 2015, 10:6469-6476

Published Date: 13 October 2015

Biomimetics: forecasting the future of science, engineering, and medicine

Hwang J, Jeong Y, Park JM, Lee KH, Hong JW, Choi J

International Journal of Nanomedicine 2015, 10:5701-5713

Published Date: 8 September 2015

Potential toxicity of dental nanomaterials to the central nervous system

Solla DF, Paiva TS, André M, Paiva WS

International Journal of Nanomedicine 2015, 10:5593-5596

Published Date: 3 September 2015

Compound antimalarial ethosomal cataplasm: preparation, evaluation, and mechanism of penetration enhancement

Shen S, Liu SZ, Zhang YS, Du MB, Liang AH, Song LH, Ye ZG

International Journal of Nanomedicine 2015, 10:4239-4253

Published Date: 30 June 2015

Enzyme-responsive nanocomposites for wound infection prophylaxis in burn management: in vitro evaluation of their compatibility with healing processes

Grützner V, Unger RE, Baier G, Choritz L, Freese C, Böse T, Landfester K, Kirkpatrick CJ

International Journal of Nanomedicine 2015, 10:4111-4124

Published Date: 24 June 2015

Optimized zein nanospheres for improved oral bioavailability of atorvastatin

Hashem FM, Al-Sawahli MM, Nasr M, Ahmed OA

International Journal of Nanomedicine 2015, 10:4059-4069

Published Date: 19 June 2015

Formulation optimization of galantamine hydrobromide loaded gel drug reservoirs in transdermal patch for Alzheimer’s disease

Woo FY, Basri M, Fard Masoumi HR, Ahmad MB, Ismail M

International Journal of Nanomedicine 2015, 10:3879-3886

Published Date: 5 June 2015